Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Vivus Stock Jumps 12.5% On Drug Approval
Vivus Stock Jumps 12.5% On Drug Approval
Vivus Stock Jumps 12.5% On Drug Approval
Submitted by
admin
on July 18, 2012 - 12:14pm
Source:
Investors.com
News Tags:
Vivus
approval
Qnexa
Qsymia
obesity
Headline:
Vivus Stock Jumps 12.5% On Drug Approval
Do Not Allow Advertisers to Use My Personal information
